HF
NVRO

HRT Financial’s NEVRO CORP. NVRO Stock Holding History

HRT Financial’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,380
Closed -$169K – 3449
2024
Q3 		$169K Buy
30,380
+328
+1% +$2.29K ﹤0.01% 2008
2024
Q2 		$253K Sell
30,052
-50,456
-63% -$538K ﹤0.01% 1566
2024
Q1 		$1.16M Buy
+80,508
New +$1.33M 0.01% 817
2023
Q3 		– Sell
-30,177
Closed -$767K – 3258
2023
Q2 		$767K Sell
30,177
-36,756
-55% -$1.06M 0.01% 1111
2023
Q1 		$2.42M Sell
66,933
-2,649
-4% -$93K 0.03% 502
2022
Q4 		$2.75M Buy
+69,582
New +$2.89M 0.04% 452
2022
Q1 		– Sell
-14,549
Closed -$1.18M – 4029
2021
Q4 		$1.18M Buy
14,549
+12,002
+471% +$1.2M 0.01% 982
2021
Q3 		$296K Sell
2,547
-718
-22% -$94K ﹤0.01% 2416
2021
Q2 		$541K Sell
3,265
-5,098
-61% -$796K 0.01% 1691
2021
Q1 		$1.17M Buy
+8,363
New +$1.36M 0.01% 981
2020
Q4 		– Sell
-4,095
Closed -$570K – 2596
2020
Q3 		$570K Buy
+4,095
New +$547K 0.02% 816
2019
Q1 		– Sell
-7,416
Closed -$288K – 833
2018
Q4 		$288K Buy
7,416
+3,762
+103% +$167K 0.04% 368
2018
Q3 		$208K Buy
+3,654
New +$228K 0.03% 323

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

HRT Financial's NVRO Position: Q4 2024 in Review

HRT Financial sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 30,380 shares — an estimated $169K sold.

HRT Financial first reported a position in NVRO in Q3 2018 and held it in 13 quarters. The position peaked at $2.75M in Q4 2022. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • HRT Financial reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 30,380 NEVRO CORP. shares in Q4 2024, an estimated $169K.
  • HRT Financial first reported a position in NEVRO CORP. in Q3 2018 and held it in 13 quarters.
  • HRT Financial's NEVRO CORP. position peaked at $2.75M in Q4 2022.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.